We aimed to determine whether cerebrospinal fluid (CSF) alpha-internexin (AINX) concentrations are associated with disease severity and outcome in GBS.<h4>Methods</h4>This retrospective cohort included 100 GBS patients. The gene discussed is INA; the disease is Guillain-Barre syndrome.